Moderna, Inc. (MRNA)
Moderna Market Cap : 19.96B for Feb. 24, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Gilead Sciences, Inc. | 183.70B |
| Johnson & Johnson | 593.62B |
| Eli Lilly & Co. | 986.03B |
| Merck & Co., Inc. | 308.99B |
| Pfizer Inc. | 154.62B |
Market Cap Related Metrics
| PS Ratio | 10.22 |
| Price to Book Value | 2.307 |
| Price | 51.08 |
| Earnings Yield | -14.22% |